Tracked deals
3
3 tracked deals across 2022-2026.
Bethesda, Maryland, United States
Technology-enabled patient services partner providing high-touch support to accelerate patient initiation and adherence for specialty therapies. Uses proprietary digital benefit investigation intelligence and data-driven insights, combined with a skilled operations team, to improve speed and accuracy of patient access for specialty medications.
Tracked deals
3
3 tracked deals across 2022-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 3 years
Supporting Data
CareMetx acquired Cencora’s U.S. hub consulting services operations previously conducted under the Lash Group, including TheraCom free goods pharmacy operations. The deal expands CareMetx’s end-to-end patient access platform by adding full-service hub operations, patient access staffing infrastructure, and free goods pharmacy fulfillment.
CareMetx has acquired PX Technology to integrate PX's digital patient-access solutions (PX Connect, PX ePA, PX Consent) into CareMetx's hub services platform, aiming to speed and simplify access to specialty medications. The deal combines CareMetx's patient support services and manufacturer relationships with PX Technology's provider-focused digital tools and network of 1,300+ healthcare providers to improve provider workflows and patient treatment initiation.
CareMetx, a technology-enabled hub services company focused on patient access to specialty medications, has acquired Human Care Systems (HCS) to add HCS's Resilix patient-adherence platform and services. The deal expands CareMetx's capabilities across the patient journey from initiation through adherence; HCS CEO Matt Hall will continue as President of HCS within the combined organization.
Turn tracked acquisition activity into an outreach-ready buyer list.